Coppell Advisory Solutions’s VanEck Pharmaceutical ETF PPH Stock Holding History

Coppell Advisory Solutions’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-54	Closed	-$5.09K	–	2054
2024 Q3	$5.09K	Buy	54 +1	+2%	+$95	﹤0.01%	1251
2024 Q2	$4.89K	Buy	+53	New	+$4.73K	﹤0.01%	1205
2023 Q4	$4.31K	Buy	53 +1	+2%	+$78	﹤0.01%	1132
2023 Q3	$4.05K	Hold	52	–	–	﹤0.01%	750
2023 Q2	$4.1K	Buy	+52	New	+$4.07K	﹤0.01%	888
2023 Q1	–	Sell	-52	Closed	-$4.05K	–	833
2022 Q4	$4.05K	Buy	+52	New	+$3.84K	﹤0.01%	754

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Coppell Advisory Solutions's PPH Position: Q4 2024 in Review

Coppell Advisory Solutions sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 54 shares — an estimated $5.09K sold.

Coppell Advisory Solutions first reported a position in PPH in Q4 2022 and held it in 6 quarters. The position peaked at $5.09K in Q3 2024. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

Coppell Advisory Solutions reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
Coppell Advisory Solutions sold 54 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $5.09K.
Coppell Advisory Solutions first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and held it in 6 quarters.
Coppell Advisory Solutions's VanEck Pharmaceutical ETF position peaked at $5.09K in Q3 2024.
142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on Coppell Advisory Solutions's 13F filing for Q4 2024, filed 14 Feb 2025.